Meningococcal Vaccine Study for Infants

Now Open in Hastings, NE

Invasive meningococcal disease (IMD) is a serious illness caused by the bacterium Neisseria meningitidis (N. Meningitidis). Symptoms may include headache, fever, nausea, vomiting, photophobia, stiff neck, lethargy, myalgia, and a characteristic petechial rash. Your child may be eligible to receive study-related care and an investigative meningococcal vaccine at no cost through a clinical study.

Eligible participants…

  • Must be age 6 to 7 months
  • May receive compensation for study-related time and travel
  • Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.

You can also talk to a Meridian enrollment specialist about this study by calling (712) 639-6200 (Meridian's Midwest call center).

Study Location

Hastings (Pediatrics)
2115 N. Kansas Ave., Suite 102
Hastings, NE 68901

Submit your information

Expect Excellence icon - supporting research since 1999

Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.